Deal Announcement

Fortlane Partners advised founders and management of Arsipa

Fortlane Partners advised founders and management of Arsipa on their entry into a strategic partnership with Warburg Pincus 

Due Diligence
Healthcare and Life Sciences
Lesezeit 2 Minutes
Transaction
Juni 2024
Icon: flag-DEIcon: flag-US

Fortlane Partners advised

founders and management with a

Commercial Vendor Due Diligence

on the sale of Arsipa GmbH

value not disclosed

A team of Fortlane Partners advised the founders and management of Arsipa GmbH ("Arsipa") on their entry into a strategic partnership with Warburg Pincus with a Commercial Vendor Due Diligence.

The project included a comprehensive depiction of Arsipa's business model and group value proposition, a detailed bottom-up quantification of the Company's addressed occupational health and safety (OHS) as well as adjacent quality, health, safety and environmental protection (QHSE) market potentials, an in-depth analysis of its competitive positioning as leading private platform in a fragmented German market environment, and a thorough feasibility assessment of key organic and inorganic growth levers.

This transaction marks one of the first buyout deals in OHS in Germany and confirms our positioning as commercial advisor of choice in the QHSE and corporate wellbeing space.

About Arsipa
Founded in 2020 in Berlin by Felix Jander and Stefan Schmidt, Arsipa is a leading group of companies providing occupational health and safety services (OHS) across the DACH region. Currently comprising more than 750 employees, the Arsipa group is continuing to accelerate its digital transformation, drive innovation and strengthen its market position through strategic acquisitions and succession solutions.

About Warburg Pincus 
Warburg Pincus LLC is the pioneer of private equity global growth investing. A private partnership since 1966, the firm has the flexibility and experience to focus on helping investors and management teams achieve enduring success across market cycles. Today, the firm has more than $87 billion in assets under management and more than 220 companies in their active portfolio. 

 

 

Transaction Team

Dr. Gerrit Schütte
Managing Director
Email

Andreas Haselbach
Manager

Richard Nowack
Senior Consultant

Urban Maier
Consultant

Marc-Philippe Leitzbach
Associate Consultant

Kontakt

Dr. Gerrit Schütte
Dr. Gerrit Schütte
Managing Director
Due Diligence, Value Creation and Exit Readiness, Portfolio Strategy and Buy & Build, Principal Investors and Private Equity, Industrials and Automotive

Weitere TransaktionenDas könnte Sie auch interessieren...

März 2023
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Polygon S.p.A. with a

Commercial Vendor Due Diligence

on its sale

value not disclosed

Mai 2022
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Clonit S.r.l. with a

Commercial Vendor Due Diligence

on its sale

value not disclosed

Mai 2022
Icon: flag-FRIcon: flag-IT

goetzpartners advised

Insec Equity Partners SGR S.p.A. with a

Commercial Vendor Due Diligence

on the sale of Plurima S.p.A.

value not disclosed

März 2022
Icon: flag-ITIcon: flag-IT

goetzpartners advised

Mipharm S.p.A. with a

Commercial Vendor Due Diligence

on its sale

value not disclosed

November 2020
Icon: flag-GBIcon: flag-DE

goetzpartners advised

Silverfleet Capital with a

Commercial Vendor Due Diligence

on the sale of 7days

value not disclosed